Chemular
Chemular is a private regulatory consulting firm serving tobacco and nicotine manufacturers with PMTA preparation, FDA submission strategy, toxicology testing, and PACT Act/excise tax compliance, supplemented by active-ingredients distribution and a blockchain-based age-gating JV (IKE Tech).
- Company typePrivate
- Founded2015
- HeadquartersHudson, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Chemular does
Chemular is a privately-held regulatory consulting firm founded in 2015 by industry and FDA veterans, headquartered in Hudson, Michigan (with corporate domicile in Ontario, Canada as Chemular International Inc.). The firm specializes in tobacco and nicotine regulatory compliance, providing a vertically-integrated suite of services including PMTA (Premarket Tobacco Product Application) preparation and FDA submission strategy, toxicological and clinical testing, product development, manufacturing solutions, and PACT Act / excise tax compliance for distributors and retailers. Chemular reports having supported PMTA submissions on 200+ products and operates a worldwide team of 35+ scientists, toxicologists, clinical trial experts, and regulatory project managers.
Its core technology stack combines traditional regulatory consulting with proprietary compliance infrastructure. Through its CMX (Chemular Market Xcellerator) offering the firm bundles product R&D, technology strategy, contract manufacturing, novel ingredients and IP licensing, and an AI-augmented capability branded 'Tobacco Titan AI.' Separately, Chemular co-founded IKE Tech LLC in February 2024 with Ispire Technology and Berify (Touchpoint World Wide), which has developed a blockchain-based, AI-powered age-gating platform for ENDS products including biometric verification, geo-fencing, and a patented 'Human Identity Token.' The JV received SOC 2 Type II certification, won dual 2026 Age Assurance Industry Awards, and its standalone PMTA for the age-gating technology was accepted by FDA in June 2025.
Chemular monetizes through professional services engagements (quote-based consulting for PMTA, regulatory strategy, and tax compliance), active-ingredients distribution via its North America Nicotine (NAN) subsidiary — described as North America's largest distributor of premium nicotine raw materials — and increasingly through licensing arrangements tied to the IKE Tech platform (e.g., the April 2026 Charlie's Holdings deal). Its customer base is concentrated in the tobacco and nicotine manufacturing vertical, with named enterprise clients including Glas Inc., Black Buffalo, Nic Nac Naturals, and White Fox. Go-to-market is sales-led direct engagement, supplemented by content marketing, TSRC/TPE/FDLI conference presence, and thought-leadership publications.
Chemular firmographics
Firmographics- Name
- Chemular
- Legal name
- Chemular International Inc.
- Website
- https://chemular.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Chemular is a private regulatory consulting firm serving tobacco and nicotine manufacturers with PMTA preparation, FDA submission strategy, toxicology testing, and PACT Act/excise tax compliance, supplemented by active-ingredients distribution and a blockchain-based age-gating JV (IKE Tech).
- Ownership category
- akta.pro rank
Chemular industry classification
Industry- Product category
- Tobacco Regulatory Consulting
- NAICS
- Tobacco Product and Electronic Cigarette Merchant Wholesalers (42494), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Tobacco Products (2100), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Smoking Cessation & Nicotine Replacement Therapy (NRT) (HLAIADAH)
- akta.pro secondary industries
- Nicotine Pouches (Tobacco-Free) Manufacturing & Brands (CRADAJAI), E-liquids & Nicotine Salts Manufacturing & Brands (CRADAJAG), Smokeless Tobacco (Chewing Tobacco, Snuff, Snus) Manufacturing & Brands (CRADAJAC)
Keywords
Where Chemular is headquartered
LocationHeadquarters
- HQ city
- Hudson
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Chemular business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Regulatory Consulting Services: Professional consulting services for tobacco regulatory compliance, including PMTA preparation, FDA submissions, and regulatory strategy
- Active Ingredients Distribution: Distribution of premium nicotine raw materials through North America Nicotine (NAN) subsidiary
- Tax Compliance Services: PACT Act and excise tax compliance reporting services
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Chemular product offering
Product offeringCore offering
Chemular is a regulatory consulting firm that helps tobacco and nicotine product manufacturers navigate FDA compliance, including Premarket Tobacco Product Application (PMTA) preparation and submission, regulatory strategy, and product development. The firm also distributes premium nicotine raw materials through its North America Nicotine affiliate and provides automated multi-state excise tax compliance services under a Compliance-as-a-Service model. Through the IKE Tech joint venture, Chemular co-develops blockchain-based biometric age-gating technology for ENDS products.
Product overview
Chemular is a worldwide regulatory consultancy specializing in tobacco and nicotine market segments. The company offers a vertically-integrated suite of regulatory and manufacturing solutions including Regulatory Consulting, Active Ingredients supply, Tax Compliance services, and the Chemular Market Xcellerator (CMX) for product development. Through a joint venture (IKE Tech LLC) with Ispire Technology Inc. and Berify, Chemular also offers proprietary age-gating technology for ENDS products using blockchain and biometric verification. CMX encompasses Product R&D, Technology Strategy, Contract Manufacturing, Novel Ingredients & Process, and Intellectual Property Licensing, with Tobacco Titan AI as an innovation capability.
Differentiator
Problem solved
Functional benefit
Brands
- CMX: Chemular Market Xcellerator offering full-range product development, regulatory strategy and manufacturing solutions
- Tobacco Titan AI
- IKE Tech LLC
Products and services
- Regulatory Consulting Comprehensive regulatory consulting services for tobacco and nicotine product manufacturers, including Premarket Tobacco Product Application (PMTA) preparation, submission, and FDA compliance strategy. For manufacturers, brands, and distributors seeking FDA authorization.
- Active Ingredients (North America Nicotine) Supply chain and consulting for active ingredients in nicotine and tobacco products, distributed through the North America Nicotine affiliate. For nicotine product manufacturers and brands requiring premium raw material supply.
- Tax Compliance Services (Compliance as a Service / CaaS) Automated multi-state excise tax compliance platform that tracks tax rates, calculates taxes, generates state-specific reports, and maintains audit-ready records. For tobacco distributors, retailers, and manufacturers with multi-state tax obligations and PACT Act reporting requirements.
- Chemular Market Xcellerator (CMX) Integrated product development, regulatory strategy, and manufacturing solutions sub-brand bundling product R&D, technology strategy, contract manufacturing, novel ingredients and processes, and intellectual property licensing. For brands and manufacturers looking to launch products in the tobacco and nicotine market.
- IKE Tech Age-Gating Technology Blockchain-based, AI-powered age-gating technology for ENDS products featuring biometric age verification, geo-fencing, real-time biometric identity platform, and patented Human Identity Token for user access control. Developed through the IKE Tech joint venture among Ispire Technology Inc., Berify, and Chemular Inc. For ENDS manufacturers seeking FDA-compliant youth-access prevention technology.
Quantifiable outcome
- First-ever FDA Marketing Granted Orders (MGOs) for flavored ENDS products incorporating Device Access Restriction technology
- +1 more outcomes
Companies that use Chemular
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
Chemular technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
Chemular partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- Charlie's HoldingsflagshipLicensing agreement to commercialize IKE Tech's blockchain-based, continuous age-gated vape system in the U.S., including test marketing of the age-gated SBX disposable vape product.
- Ispire Technology Inc.coreJoint venture partnership to pioneer next-generation e-cigarette age-verification technology. Combines Ispire's hardware expertise with Chemular's regulatory consulting and PMTA know-how to develop and commercialize age-gating compliance solutions for the ENDS market.
- Touchpoint World Wide Inc. (Berify)coreJoint venture partnership leveraging Berify's multi-patented blockchain technology and digital engagement platform combined with Chemular's regulatory expertise to create age-verification solutions for vapor devices.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Chemular competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Global testing, inspection, and certification giant with significant tobacco/nicotine testing operations (including Labstat). Comparable on the testing/lab-services side that Chemular provides to PMTA clients, though operates at vastly larger scale across many industries.
- NAMSA: Medical device-focused CRO with regulatory consulting and testing capabilities. Comparable in regulatory science and testing services that overlap with Chemular's medical-device regulatory heritage, though broader in device than tobacco.
- Charles River Laboratories: Large CRO offering preclinical safety, toxicology, and regulatory services across pharma and medical devices. Comparable toxicological and scientific testing depth that supports Chemular's PMTA work, though at much broader scale.
- ICON plc: Large global CRO offering clinical, regulatory, and consulting services to pharma and medical device clients. Comparable regulatory consulting capabilities though much broader and larger scale; could potentially compete for tobacco-adjacent regulatory work.
Emerging players
- Certeza Consulting: Boutique regulatory and quality consulting firm focused on FDA submissions and compliance for medical devices, pharma, and tobacco products. Smaller-scale but comparable boutique regulatory profile targeting PMTA-style submissions.
- Ispire Technology Inc. Public vape hardware technology company and IKE Tech JV partner. Comparable in serving the ENDS regulatory and age-gating space; partner rather than competitor but operates in adjacent technology/compliance layer.
Direct peers
- Labstat International (Eurofins): Tobacco-focused analytical testing and consulting firm (acquired by Eurofins) providing HPHC testing, product characterization, and PMTA-supporting scientific studies. Comparable to Chemular's HPHC, toxicological, and bioequivalence testing services for tobacco/nicotine clients.
- Broughton Group: UK-headquartered regulatory and scientific consultancy providing product chemistry, toxicology, and regulatory support to tobacco, e-cigarette, and pharmaceutical clients. Comparable niche consulting profile and tobacco/nicotine focus to Chemular.
- PinneyAssociates: U.S.-based consulting firm specializing in pharmaceutical, tobacco, and nicotine regulatory science, including PMTA support and risk assessment. Directly comparable service offering to Chemular's regulatory consulting arm.
- Advena Limited: Specialist regulatory consultancy providing medical device, IVD, and tobacco/nicotine regulatory services in the UK and EU. Highly comparable to Chemular given similar boutique regulatory focus, particularly in tobacco and nicotine product approvals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Chemular social profiles
Digital presenceChemular compliance and trust
Trust signalCompliance2 records
Chemular financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chemular leadership team
Management profileNumber of profiles
Profiles1 record
Chemular funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chemular M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chemular
What does Chemular do?
Chemular is a regulatory consulting firm that helps tobacco and nicotine product manufacturers navigate FDA compliance, including Premarket Tobacco Product Application (PMTA) preparation and submission, regulatory strategy, and product development. The firm also distributes premium nicotine raw materials through its North America Nicotine affiliate and provides automated multi-state excise tax compliance services under a Compliance-as-a-Service model. Through the IKE Tech joint venture, Chemular co-develops blockchain-based biometric age-gating technology for ENDS products.
Is Chemular a public or private company?
Chemular is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Chemular founded?
Chemular was founded in 2015. It employs 11 to 50 people.
Where is Chemular based?
Chemular is headquartered in Hudson, United States, in the North America region.
How does Chemular make money?
Three revenue lines are on record. Regulatory Consulting Services are the primary driver. The others are active Ingredients Distribution and tax Compliance Services.
Who are Chemular's main competitors?
Broad incumbents on record are Eurofins Scientific, NAMSA, Charles River Laboratories and ICON plc. Emerging players are Certeza Consulting and Ispire Technology Inc.. Direct peers are Labstat International (Eurofins), Broughton Group, PinneyAssociates and Advena Limited.
Does Chemular have an API?
No public API is recorded for Chemular.
What industry is Chemular in?
Chemular's product category is Tobacco Regulatory Consulting. Its primary akta.pro industry code is HLAIADAH, Smoking Cessation & Nicotine Replacement Therapy (NRT), with a secondary code of CRADAJAI, Nicotine Pouches (Tobacco-Free) Manufacturing & Brands. Its NAICS code is 42494 and its SIC code is 2100.